Combo-PEP: Multipurpose Prevention of Post-Exposure Prophylaxis Regimens
Latest Information Update: 25 May 2023
At a glance
- Drugs Bictegravir/emtricitabine/tenofovir alafenamide (Primary) ; Doxycycline (Primary)
- Indications HIV infections; Sexually transmitted infections
- Focus Pharmacokinetics
- Acronyms Combo-PEP
- 20 Sep 2022 Status changed from recruiting to completed.
- 05 Aug 2021 Status changed from not yet recruiting to recruiting.
- 04 May 2021 New trial record